Actinium Pharmaceuticals, Inc. (Delaware) (ATNM)
Actinium Pharmaceuticals, Inc. (Delaware) (ATNM)
$0.24 USD
Updated Sep 20 12:00am
Add ATNM to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
ATNM Stock Chart More Charts
ATNM Price/Volume Stats
| Current price | $0.24 |
| Prev. close | $0.23 |
| Day low | $0.22 |
| Day high | $0.24 |
| 50-day MA | $0.23 |
| 200-day MA | $0.37 |
| 52-week high | $0.87 |
| 52-week low | $0.19 |
| Volume | 371,400 |
| Avg. volume | 1,032,890 |
| Dividend yield | N/A |
| Market Cap | 38.98M |
Actinium Pharmaceuticals, Inc. (Delaware) (ATNM) Company Bio
Actinium Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted payload immunotherapeutics for the treatment of advanced cancers. The companys targeted radio immunotherapy products are based on its proprietary delivery platform for the therapeutic utilization of alpha-emitting Actinium-225 and Bismuth-213, and certain beta emitting radiopharmaceuticals in conjunction with monoclonal antibodies. The company was founded in 2000 and is based in New York City, New York.
Top Stories View All
Why this analyst just rated shares of HEXO a “buy”
What is the Worst Case Scenario for Stocks?
Best & Worst Performing Stock Industries for September 20, 2019
Best & Worst Performing Small Cap Stocks for September 20, 2019
Best & Worst Performing Mid Cap Stocks for September 20, 2019
View All Top Stories
Loading social stream, please wait...